Related Experiment Video
Updated: Dec 14, 2025
04:56
Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
380
MicroRNAs in ascending thoracic aortic aneurysms.
Areti Moushi1, Nir Pillar2, Anna Keravnou1,3
1Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Bioscience Reports
|July 18, 2020
Summary
Researchers identified three microRNAs (miRNAs) as potential early diagnostic biomarkers for ascending thoracic aortic aneurysm (aTAA). These findings may also lead to new therapeutic targets for this fatal cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Biomarker Discovery
Background:
- Thoracic Aortic Aneurysm (TAA) involves aortic dilation and is often fatal if untreated.
- The genetic underpinnings of TAA remain incompletely understood, necessitating research into its pathophysiology.
- MicroRNAs (miRNAs) are key post-transcriptional regulators implicated in cardiovascular diseases (CVDs).
Purpose of the Study:
- To identify potential microRNA (miRNA) biomarkers for the early diagnosis of ascending thoracic aortic aneurysms (ATAAs).
- To explore novel therapeutic targets for ATAA based on miRNA expression profiles.
Main Methods:
- MiRNA expression profiling was performed using NanoString nCounter technology on tissue and plasma samples from ATAA patients.
- Quantitative validation of selected miRNAs was conducted using real-time polymerase chain reaction (RT-PCR).
- Bioinformatic analysis identified predicted target genes and their correlation with miRNA expression.
Main Results:
- Three specific miRNAs (hsa-miR140-5p, hsa-miR-191-5p, and hsa-miR-214-3p) exhibited significant expression differences in plasma samples.
- Expression levels of two target genes, MTMR4 and PPP1CB, were inversely correlated with their corresponding miRNAs.
- This pilot study highlights potential diagnostic and therapeutic avenues for ATAA.
Conclusions:
- Identified three miRNAs as potential non-invasive biomarkers for early ATAA detection.
- These miRNAs and their target genes represent potential targets for future ATAA therapies.
- Further research is warranted to validate these findings and explore therapeutic applications.
Related Concept Videos
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
119
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
119
01:26Aneurysm III: Interprofessional Care
154
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
154
01:30Aneurysm I: Introduction
184
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
184
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
264
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
264
01:15Aortic Regurgitation I: Introduction
302
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
302
01:15Thoracic Aorta
1.3K
The thoracic section of the aorta begins at the T5 vertebra and extends to the T12 level at the diaphragm, initially progressing through the mediastinum to the left of the spinal column. Throughout its course in the thoracic segment, the thoracic aorta emits various offshoots known collectively as visceral and parietal branches. The branches that predominantly supply blood to visceral organs are termed visceral branches and include bronchial, pericardial, esophageal, and mediastinal arteries,...
1.3K